162 related articles for article (PubMed ID: 26958783)
1. The effect of age on peripheral stem cell mobilization in healthy donors, single center experience.
Ozen M; Gunduz M; Topcuoglu P; Toprak SK; Dalva K; Gurman G; Ilhan O
J Clin Apher; 2017 Feb; 32(1):16-20. PubMed ID: 26958783
[TBL] [Abstract][Full Text] [Related]
2. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
3. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center.
Bailén R; Pérez-Corral AM; Pascual C; Kwon M; Serrano D; Gayoso J; Balsalobre P; Muñoz C; Díez-Martín JL; Anguita J
J Clin Apher; 2019 Aug; 34(4):373-380. PubMed ID: 30694583
[TBL] [Abstract][Full Text] [Related]
5. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?
Lysák D; Kořístek Z; Gašová Z; Skoumalová I; Jindra P
J Clin Apher; 2011; 26(1):9-16. PubMed ID: 21312254
[TBL] [Abstract][Full Text] [Related]
7. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
[TBL] [Abstract][Full Text] [Related]
8. Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
Hsu JW; Shaw BE; Kim S; Logan BR; Sees JA; Confer DL; Pulsipher MA; Shah N; Switzer GE; Abidi MH; Ahmed IA; Anderlini PN; Bredeson C; Chhabra S; Dandoy CE; Diaz MA; Farhadfar N; Ganguly S; Gergis U; Hale GA; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Murthy HS; Olsson RF; Savani BN; Schears R; Seo S; Solh M; Spitzer T; Steinberg A; Sugrue M; Warkentin P; Wingard JR
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1210-1217. PubMed ID: 32088366
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
[TBL] [Abstract][Full Text] [Related]
11. [Factors affecting mobilization of peripheral blood stem/progenitor cells and apheresis efficiency from healthy donors by rhG-CSF].
Liang ZY; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):847-51. PubMed ID: 18718074
[TBL] [Abstract][Full Text] [Related]
12. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
Namba N; Matsuo K; Kubonishi S; Kikuchi T; Maeda Y; Niiya M; Shinagawa K; Koide N; Ikeda K; Tanimoto M
Transfusion; 2009 Nov; 49(11):2384-9. PubMed ID: 19624602
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
Díaz MA; Sevilla J; de la Rubia J; Verdeguer A; Espigado I; Vicent MG; Pascual MJ; Zamora C; Arrieta R; Serrano D; del Cañizo C; Arbona C; de Arriba F; Bargay J; Brunet S; Sanz MA
Haematologica; 2003 Aug; 88(8):919-22. PubMed ID: 12935980
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
Kröger N; Renges H; Krüger W; Gutensohn K; Löliger C; Carrero I; Cortes L; Zander AR
Br J Haematol; 2000 Dec; 111(3):761-5. PubMed ID: 11122135
[TBL] [Abstract][Full Text] [Related]
15. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
[TBL] [Abstract][Full Text] [Related]
16. Effect of G-CSF on peripheral blood progenitor cell mobilization and collection from healthy donors.
Chaisiripoomkere W; Jootar S; Ungkanont A
Asian Pac J Allergy Immunol; 2001 Sep; 19(3):183-90. PubMed ID: 11826913
[TBL] [Abstract][Full Text] [Related]
17. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
[TBL] [Abstract][Full Text] [Related]
18. Mobilization factors of peripheral blood stem cells in healthy donors.
Shimizu N; Asai T; Hashimoto S; Narita M; Kobayashi M; Ito M; Onoda M; Yokota A; Cho R; Nakaseko C; Nishimura M; Saito Y
Ther Apher; 2002 Dec; 6(6):413-8. PubMed ID: 12460403
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
[TBL] [Abstract][Full Text] [Related]
20. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
Kröger N; Renges H; Sonnenberg S; Krüger W; Gutensohn K; Dielschneider T; Cortes-Dericks L; Zander AR
Bone Marrow Transplant; 2002 May; 29(9):727-30. PubMed ID: 12040468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
